Compare $ALGS vs $BIOQ | Chartloom

Compare

$ALGS vs $BIOQ

Aligos Therapeutics Inc · Bioqual Inc

ALGS

Aligos Therapeutics Inc

BIOQ

Bioqual Inc

Compare $ALGS vs $BIOQ

Comparing Aligos Therapeutics Inc and Bioqual Inc

ALGSAligos Therapeutics Inc

BIOQBioqual Inc

ALGSAligos Therapeutics Inc

Market cap

$33M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.83x

Rev growth (TTM)

893.0%

YTD performance

-41.5%

52W performance

-46.2%

FCF yield

-286.0%

BIOQBioqual Inc

Market cap

$29M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-19.4%

YTD performance

-14.3%

52W performance

-40.0%

FCF yield

20.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALGS

BIOQ

Detailed metrics comparison

ALGS

Aligos Therapeutics Inc

BIOQ

Bioqual Inc

Market Cap

ALGS$33M

BIOQ$29M

Enterprise Value

ALGS$3M

BIOQ$18M

Price

ALGS$5.34

BIOQ$33.00

P/E Ratio

ALGSN/A

BIOQN/A

P/S Ratio

ALGS1.05x

BIOQ0.69x

EV/Sales

ALGS0.09x

BIOQ0.43x

EV/EBITDA

ALGS0.00x

BIOQ7.55x

P/B Ratio

ALGS1.09x

BIOQ0.84x

P/FCF Ratio

ALGSN/A

BIOQ4.95x

EV/FCF

ALGS-0.03x

BIOQ3.05x

PEG Ratio

ALGSN/A

BIOQN/A

Forward P/E (NTM)

ALGSN/A

BIOQN/A

Forward P/S (NTM)

ALGS4.83x

BIOQN/A

Revenue (TTM)

ALGS$32M

BIOQ$42M

Revenue Growth (YoY)

ALGS893.0%

BIOQ-19.4%

Forward Rev Growth

ALGS-84.9%

BIOQ0.0%

Gross Margin (TTM)

ALGS0.0%

BIOQ7.9%

Operating Margin (TTM)

ALGS0.0%

BIOQ0.0%

EBITDA Margin (TTM)

ALGS-247.2%

BIOQ-0.1%

Net Margin (TTM)

ALGS-241.0%

BIOQ-2.9%

FCF Margin (TTM)

ALGS-299.9%

BIOQ14.0%

Net Income (TTM)

ALGS$-76M

BIOQ$-1M

FCF (TTM)

ALGS$-95M

BIOQ$6M

EPS (TTM)

ALGS-$7.28

BIOQ-$1.38

ROE (TTM)

ALGS-16072.0%

BIOQ-346.0%

ROA (TTM)

ALGS-9230.0%

BIOQ-193.0%

ROIC (TTM)

ALGS-16035.0%

BIOQ-346.0%

Cash

ALGS$30M

BIOQ$11M

Debt

ALGS$64K

BIOQ$0

Net Cash/Debt

ALGS$30M

BIOQ$11M

Current Ratio (TTM)

ALGS2.19x

BIOQ4.01x

Quick Ratio (TTM)

ALGS2.19x

BIOQ3.91x

Debt/Equity (TTM)

ALGS0.00x

BIOQ0.00x

Debt/Assets (TTM)

ALGS0.0%

BIOQ0.0%

Interest Coverage (TTM)

ALGSN/A

BIOQN/A

Net Debt/EBITDA (TTM)

ALGS0.00x

BIOQ0.00x

Beta

ALGS2.48

BIOQ-0.48

52W Performance

ALGS-46.2%

BIOQ-40.0%

YTD Performance

ALGS-41.5%

BIOQ-14.3%

% from 52W High

ALGS-61.0%

BIOQ-69.6%

% from 52W Low

ALGS34.2%

BIOQ1.5%

Asset Turnover (TTM)

ALGS0.38x

BIOQ0.66x

FCF Yield (TTM)

ALGS-286.0%

BIOQ20.2%

Earnings Yield (TTM)

ALGS-229.8%

BIOQ-4.2%

Dividend Yield (TTM)

ALGSN/A

BIOQN/A

Rule of 40

ALGS593.1

BIOQ-5.4

EV/GP/RG

ALGSN/A

BIOQN/A

Ticker research

View ALGS research View BIOQ research

Metric	ALGS Aligos Therapeutics Inc	BIOQ Bioqual Inc
Market & Valuation
Market Cap	$33M	$29M
Enterprise Value	$3M	$18M
Price	$5.34	$33.00
P/E Ratio	N/A	N/A
P/S Ratio	1.05x	0.69x
EV/Sales	0.09x	0.43x
EV/EBITDA	0.00x	7.55x
P/B Ratio	1.09x	0.84x
P/FCF Ratio	N/A	4.95x
EV/FCF	-0.03x	3.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.83x	N/A
Revenue & Growth
Revenue (TTM)	$32M	$42M
Revenue Growth (YoY)	893.0%	-19.4%
Forward Rev Growth	-84.9%	0.0%
Profitability
Gross Margin (TTM)	0.0%	7.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-247.2%	-0.1%
Net Margin (TTM)	-241.0%	-2.9%
FCF Margin (TTM)	-299.9%	14.0%
Net Income (TTM)	$-76M	$-1M
FCF (TTM)	$-95M	$6M
EPS (TTM)	-$7.28	-$1.38
ROE (TTM)	-16072.0%	-346.0%
ROA (TTM)	-9230.0%	-193.0%
ROIC (TTM)	-16035.0%	-346.0%
Financial Health
Cash	$30M	$11M
Debt	$64K	$0
Net Cash/Debt	$30M	$11M
Current Ratio (TTM)	2.19x	4.01x
Quick Ratio (TTM)	2.19x	3.91x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.48	-0.48
52W Performance	-46.2%	-40.0%
YTD Performance	-41.5%	-14.3%
% from 52W High	-61.0%	-69.6%
% from 52W Low	34.2%	1.5%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.66x
FCF Yield (TTM)	-286.0%	20.2%
Earnings Yield (TTM)	-229.8%	-4.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	593.1	-5.4
EV/GP/RG	N/A	N/A
Ticker research	View ALGS research	View BIOQ research

Valuation

P/S Ratio

BIOQ

0.69x

ALGS

1.05x

EV/FCF

ALGS

-0.03x

BIOQ

3.05x

Growth & revenue

Revenue Growth TTM

ALGS

893.0%

BIOQ

-19.4%

Forward Revenue Growth

BIOQ

0.0%

ALGS

-84.9%

Profitability & performance

Gross Margin

BIOQ

7.9%

ALGS

0.0%

ROE

BIOQ

-346.0%

ALGS

-16072.0%

FCF Yield %

BIOQ

20.2%

ALGS

-286.0%

52-Week Performance

BIOQ

-40.0%

ALGS

-46.2%

Detailed metrics comparison

ALGS

Aligos Therapeutics Inc

BIOQ

Bioqual Inc

Market Cap

ALGS$33M

BIOQ$29M

Enterprise Value

ALGS$3M

BIOQ$18M

Price

ALGS$5.34

BIOQ$33.00

P/E Ratio

ALGSN/A

BIOQN/A

P/S Ratio

ALGS1.05x

BIOQ0.69x

EV/Sales

ALGS0.09x

BIOQ0.43x

EV/EBITDA

ALGS0.00x

BIOQ7.55x

P/B Ratio

ALGS1.09x

BIOQ0.84x

P/FCF Ratio

ALGSN/A

BIOQ4.95x

EV/FCF

ALGS-0.03x

BIOQ3.05x

PEG Ratio

ALGSN/A

BIOQN/A

Forward P/E (NTM)

ALGSN/A

BIOQN/A

Forward P/S (NTM)

ALGS4.83x

BIOQN/A

Revenue (TTM)

ALGS$32M

BIOQ$42M

Revenue Growth (YoY)

ALGS893.0%

BIOQ-19.4%

Forward Rev Growth

ALGS-84.9%

BIOQ0.0%

Gross Margin (TTM)

ALGS0.0%

BIOQ7.9%

Operating Margin (TTM)

ALGS0.0%

BIOQ0.0%

EBITDA Margin (TTM)

ALGS-247.2%

BIOQ-0.1%

Net Margin (TTM)

ALGS-241.0%

BIOQ-2.9%

FCF Margin (TTM)

ALGS-299.9%

BIOQ14.0%

Net Income (TTM)

ALGS$-76M

BIOQ$-1M

FCF (TTM)

ALGS$-95M

BIOQ$6M

EPS (TTM)

ALGS-$7.28

BIOQ-$1.38

ROE (TTM)

ALGS-16072.0%

BIOQ-346.0%

ROA (TTM)

ALGS-9230.0%

BIOQ-193.0%

ROIC (TTM)

ALGS-16035.0%

BIOQ-346.0%

Cash

ALGS$30M

BIOQ$11M

Debt

ALGS$64K

BIOQ$0

Net Cash/Debt

ALGS$30M

BIOQ$11M

Current Ratio (TTM)

ALGS2.19x

BIOQ4.01x

Quick Ratio (TTM)

ALGS2.19x

BIOQ3.91x

Debt/Equity (TTM)

ALGS0.00x

BIOQ0.00x

Debt/Assets (TTM)

ALGS0.0%

BIOQ0.0%

Interest Coverage (TTM)

ALGSN/A

BIOQN/A

Net Debt/EBITDA (TTM)

ALGS0.00x

BIOQ0.00x

Beta

ALGS2.48

BIOQ-0.48

52W Performance

ALGS-46.2%

BIOQ-40.0%

YTD Performance

ALGS-41.5%

BIOQ-14.3%

% from 52W High

ALGS-61.0%

BIOQ-69.6%

% from 52W Low

ALGS34.2%

BIOQ1.5%

Asset Turnover (TTM)

ALGS0.38x

BIOQ0.66x

FCF Yield (TTM)

ALGS-286.0%

BIOQ20.2%

Earnings Yield (TTM)

ALGS-229.8%

BIOQ-4.2%

Dividend Yield (TTM)

ALGSN/A

BIOQN/A

Rule of 40

ALGS593.1

BIOQ-5.4

EV/GP/RG

ALGSN/A

BIOQN/A

Ticker research

View ALGS research View BIOQ research

Metric	ALGS Aligos Therapeutics Inc	BIOQ Bioqual Inc
Market & Valuation
Market Cap	$33M	$29M
Enterprise Value	$3M	$18M
Price	$5.34	$33.00
P/E Ratio	N/A	N/A
P/S Ratio	1.05x	0.69x
EV/Sales	0.09x	0.43x
EV/EBITDA	0.00x	7.55x
P/B Ratio	1.09x	0.84x
P/FCF Ratio	N/A	4.95x
EV/FCF	-0.03x	3.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.83x	N/A
Revenue & Growth
Revenue (TTM)	$32M	$42M
Revenue Growth (YoY)	893.0%	-19.4%
Forward Rev Growth	-84.9%	0.0%
Profitability
Gross Margin (TTM)	0.0%	7.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-247.2%	-0.1%
Net Margin (TTM)	-241.0%	-2.9%
FCF Margin (TTM)	-299.9%	14.0%
Net Income (TTM)	$-76M	$-1M
FCF (TTM)	$-95M	$6M
EPS (TTM)	-$7.28	-$1.38
ROE (TTM)	-16072.0%	-346.0%
ROA (TTM)	-9230.0%	-193.0%
ROIC (TTM)	-16035.0%	-346.0%
Financial Health
Cash	$30M	$11M
Debt	$64K	$0
Net Cash/Debt	$30M	$11M
Current Ratio (TTM)	2.19x	4.01x
Quick Ratio (TTM)	2.19x	3.91x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.48	-0.48
52W Performance	-46.2%	-40.0%
YTD Performance	-41.5%	-14.3%
% from 52W High	-61.0%	-69.6%
% from 52W Low	34.2%	1.5%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.66x
FCF Yield (TTM)	-286.0%	20.2%
Earnings Yield (TTM)	-229.8%	-4.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	593.1	-5.4
EV/GP/RG	N/A	N/A
Ticker research	View ALGS research	View BIOQ research